How Risky Is Healthcare Investing?

Healthcare is changing dramatically in the U.S., leading to a challenge for private equity investors: how to underwrite risk when the risks are hard to measure? Regulatory, reimbursement and political risk are the focus of this discussion between James Elrod of Vestar Capital Partners, Sherrill Neff of Quaker Partners, and Tammy Hill of RSM.

They discuss which services and products are likely to be hit with reimbursement cutbacks and why they are closely following the development of state-level health-insurance exchanges.